WT-1 analogue peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-017577
A peptide vaccine containing a human Wilms tumor 1 (WT-1) protein-derived epitope with potential antineoplastic activity. Vaccination with the WT-1 analogue peptide vaccine may induce a cytotoxic T-lymphocyte (CTL) response against WT-1 expressing cells, resulting in tumor cell lysis and inhibition of tumor cell proliferation. WT-1, a zinc finger transcription factor, is overexpressed in most types of leukemia and in some solid cancers.
| Identifier | MLC-T-ONC-017577 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | WT-1 vax |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017577",
"term": "WT-1 analogue peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A peptide vaccine containing a human Wilms tumor 1 (WT-1) protein-derived epitope with potential antineoplastic activity. Vaccination with the WT-1 analogue peptide vaccine may induce a cytotoxic T-lymphocyte (CTL) response against WT-1 expressing cells, resulting in tumor cell lysis and inhibition of tumor cell proliferation. WT-1, a zinc finger transcription factor, is overexpressed in most types of leukemia and in some solid cancers.",
"synonyms": [
"WT-1 vax"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/wt-1-analogue-peptide-vaccine/"
}
Record 17,462 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.